col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

104 Results       Page 1

BMJ: Thorax
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―21 Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection Claire F McGroder, Mary M Salvatore, Belinda M D'Souza, Eric A Hoffman, Matthew R Baldwin, Christine Kim Garcia
2 [GO] 2023―Dec―02 Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community Emily A Kendall, Peter J Kitonsa, Annet Nalutaaya, Katherine O Robsky, Kamoga Caleb Erisa, James Mukiibi, et al. (+4)
3 [GO] 2023―Dec―02 Innocent bystanders: effects of the COVID-19 pandemic on non-COVID-19 critical illness outcomes James A Russell
4 [GO] 2023―Nov―08 COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a deadly complication Chris Kosmidis, Martin Hoenigl
5 [GO] 2023―Nov―06 Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset Helen Morgan, Savannah Gysling, Neal Navani, David Baldwin, Richard Hubbard, Emma O’Dowd
6 [GO] 2023―Sep―01 COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study William Hurt, Jonathan Youngs, Jonathan Ball, Jonathan Edgeworth, Philip Hopkins, David R Jenkins, et al. (+9)
7 [GO] 2023―Aug―16 Correction:Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data
8 [GO] 2023―Jul―09 Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus Terence Ho, Abdullah Shahzad, Aaron Jones, Natya Raghavan, Mark Loeb, Neil Johnston
9 [GO] 2023―Jun―07 Failure of TRPC6 inhibition to prevent COVID-19 deterioration: more questions than answers Elizabeth Levy, Nuala J Meyer
10 [GO] 2023―May―30 Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK) Florence Tydeman, Paul E Pfeffer, Giulia Vivaldi, Hayley Holt, Mohammad Talaei, David Jolliffe, et al. (+7)
11 [GO] 2023―May―24 Non-COVID-19 intensive care admissions during the pandemic: a multinational registry-based study Joshua McLarty, Edward Litton, Abigail Beane, Diptesh Aryal, Michael Bailey, Stepani Bendel, et al. (+21)
12 [GO] 2023―May―19 Higher SARS-CoV-2 detection of oropharyngeal compared with nasopharyngeal or saliva specimen for molecular testing: a multicentre randomised comparative accuracy study Tobias Todsen, Martin G Tolsgaard, Thomas Benfield, Fredrik Folke, Kathrine K Jakobsen, Niels Tobias Gredal, et al. (+3)
13 [GO] 2023―May―04 Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality Justin de Brabander, Leonoor S Boers, Robert F J Kullberg, Shiqi Zhang, Esther J Nossent, Leo M A Heunks, et al. (+6)
14 [GO] 2023―Apr―06 TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial Lorraine Ware, Nima Soleymanlou, Danny Francis McAuley, Vicente Estrada, George A Diaz, Peter Lacamera, et al. (+4)
15 [GO] 2023―Jan―30 Association of clinically significant obstructive sleep apnoea with risks of contracting COVID-19 and serious COVID-19 complications: a retrospective population-based study of health administrative data Tetyana Kendzerska, Marcus Povitz, Andrea S Gershon, Clodagh M Ryan, Robert Talarico, Dennys Andrea Franco Avecilla, et al. (+3)
16 [GO] 2023―Jan―03 Longitudinal follow-up of postacute COVID-19 syndrome: DLCO, quality-of-life and MRI pulmonary gas-exchange abnormalities Alexander M Matheson, Marrissa J McIntosh, Harkiran K Kooner, Mohamed Abdelrazek, Mitchell S Albert, Inderdeep Dhaliwal, et al. (+4)
17 [GO] 2022―Dec―08 High-flow nasal oxygen: benefits are hard to show in COVID-19 patients with mild hypoxaemia Arnaud W Thille, Jean-Pierre Frat
18 [GO] 2022―Nov―08 Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol Stephen R Knight, Rishi K Gupta, Antonia Ho, Riinu Pius, Iain Buchan, Gail Carson, et al. (+29)
19 [GO] 2022―Jul―28 Patient outcomes following emergency admission to hospital for COVID-19 compared with influenza: retrospective cohort study Thomas Woodcock, Geva Greenfield, Ajit Lalvani, Azeem Majeed, Paul Aylin
20 [GO] 2022―Jul―15 C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial Zelalem Temesgen, Colleen F Kelley, Frank Cerasoli, Adrian Kilcoyne, Dale Chappell, Cameron Durrant, et al. (+6)
21 [GO] 2022―Jun―29 Wheeze in the time of COVID-19: overcoming obstacles to an unusual diagnosis Mhairi Barclay, Silviu Buderi, Andrew Bush, Mat Daniel, Simon Jordan, Alexandra Rice, et al. (+3)
22 [GO] 2022―May―23 High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial Claudia Crimi, Alberto Noto, Fabiana Madotto, Mariachiara Ippolito, Santi Nolasco, Raffaele Campisi, et al. (+16)
23 [GO] 2022―May―23 COVID-19-related changes in outpatient CPAP setup pathways for OSA are linked with decreased 30-day CPAP usage Chris D Turnbull, Martin Allen, Jennifer Appleby, Richard Brown, Nathalie Bryan, Ann Cooper, et al. (+24)
24 [GO] 2022―Apr―28 COVID-19 associated phrenic nerve mononeuritis: a case series Sheonagh MacPhail Law, Kathryn Scott, Ahmed Alkarn, Aisha Mahjoub, Arup K Mallik, Giles Roditi, Brian Choo-Kang
25 [GO] 2022―Mar―31 Short-term exposure to ambient air pollution and individual emergency department visits for COVID-19: a case-crossover study in Canada Eric Lavigne, Niilo Ryti, Antonio Gasparrini, Francesco Sera, Scott Weichenthal, Hong Chen, et al. (+7)
26 [GO] 2022―Mar―30 Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19 Linzy Houchen-Wolloff, Krisnah Poinasamy, Kate Holmes, Maryrose Tarpey, Claire Hastie, Kelly Raihani, et al. (+35)
27 [GO] 2022―Mar―30 Relationship between asthma and severe COVID-19: a national cohort study Ted Dolby, Vahe Nafilyan, Ann Morgan, Constantinos Kallis, Aziz Sheikh, Jennifer K Quint
28 [GO] 2022―Mar―25 Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis Laura Fabbri, Samuel Moss, Fasihul A Khan, Wenjie Chi, Jun Xia, Karen Robinson, et al. (+3)
29 [GO] 2022―Feb―14 Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection Yue Du, Kamran M Miah, Omar Habib, Helena Meyer-Berg, Catriona C Conway, Mariana A Viegas, et al. (+8)
30 [GO] 2022―Feb―02 Validation of the 4C prediction models to inform care for patients with COVID-19: final steps towards clinical application Milo A Puhan, Mohsen Sadatsafavi
31 [GO] 2021―Dec―01 Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) Hayley Holt, Mohammad Talaei, Matthew Greenig, Dominik Zenner, Jane Symons, Clare Relton, et al. (+28)
32 [GO] 2021―Nov―24 COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study William K Gray, Annakan V Navaratnam, Jamie Day, Julia Wendon, Tim W R Briggs
33 [GO] 2021―Nov―15 External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland Colin R Simpson, Chris Robertson, Steven Kerr, Ting Shi, Eleftheria Vasileiou, Emily Moore, et al. (+9)
34 [GO] 2021―Nov―05 SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures Rebecca L Winslow, Jie Zhou, Ella F Windle, Intesar Nur, Ranjit Lall, Chen Ji, et al. (+11)
35 [GO] 2021―Oct―04 Acute and sustained increase in endothelial biomarkers in COVID-19 Raúl Méndez, Paula González-Jiménez, Ana Latorre, Mónica Piqueras, Leyre Bouzas, Katheryn Yépez, et al. (+6)
36 [GO] 2021―Sep―29 Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS Nicola Latronico, Elena Peli, Stefano Calza, Federica Rodella, Maria Paola Novelli, Andrea Cella, et al. (+4)
37 [GO] 2021―Sep―28 Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort Ashley K Clift, Adam von Ende, Pui San Tan, Hannah M Sallis, Nicola Lindson, Carol A C Coupland, et al. (+4)
38 [GO] 2021―Sep―28 A respiratory pandemic should focus the mind on tobacco control Anthony A Laverty, Christopher Millett
39 [GO] 2021―Sep―27 COVID-19 risk and mortality in hospitals: this is not a time to let our guard down Jemima T Collins, Ben Carter, Jonathan Hewitt
40 [GO] 2021―Sep―11 Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination Alison M DeDent, Erica Farrand
41 [GO] 2021―Aug―17 Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19 James P Bridges, Eszter K Vladar, Hua Huang, Robert J Mason
42 [GO] 2021―Aug―06 COVID-19 vaccine-related interstitial lung disease: a case study Ji Young Park, Joo-Hee Kim, In Jae Lee, Hwan Il Kim, Sunghoon Park, Yong Il Hwang, et al. (+2)
43 [GO] 2021―Jul―26 A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial Jian'an Li, Wenguang Xia, Chao Zhan, Shouguo Liu, Zhifei Yin, Jiayue Wang, et al. (+5)
44 [GO] 2021―Jul―23 Burden of nosocomial COVID-19 in Wales: results from a multicentre retrospective observational study of 2508 hospitalised adults Mark J Ponsford, Rhys Jefferies, Chris Davies, Daniel Farewell, Ian R Humphreys, Stephen Jolles, et al. (+7)
45 [GO] 2021―Jul―08 COVID-19 pneumonitis and cystic lung disease, pneumothorax and pneumomediastinum Serenydd Everden, Irfan Zaki, Gareth Trevelyan, James Briggs
46 [GO] 2021―Jul―05 Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data Pontus Hedberg, John Karlsson Valik, Suzanne van der Werff, Hideyuki Tanushi, Ana Requena Mendez, Fredrik Granath, et al. (+7)
47 [GO] 2021―Jun―04 Immune responses to SARS-CoV-2 in the lung Prabhu S Arunachalam
48 [GO] 2021―May―27 RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic Mark Griffiths, Susanna Meade, Charlotte Summers, Daniel Francis McAuley, Alastair Proudfoot, Marta Montero Baladia, et al. (+15)
49 [GO] 2021―Apr―29 Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length Claire F McGroder, David Zhang, Mohammad A Choudhury, Mary M Salvatore, Belinda M D'Souza, Eric A Hoffman, et al. (+3)
50 [GO] 2021―Apr―27 Shift work is associated with positive COVID-19 status in hospitalised patients Robert Maidstone, Simon G Anderson, David W Ray, Martin K Rutter, Hannah J Durrington, John F Blaikley
51 [GO] 2021―Apr―17 Correction: Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection
52 [GO] 2021―Apr―13 Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19 Anno Saris, Tom DY Reijnders, Esther J Nossent, Alex R Schuurman, Jan Verhoeff, Saskia van Asten, et al. (+8)
53 [GO] 2021―Apr―09 COVID-19 and ethnicity:has history repeated itself? Annastazia E Learoyd, Abdel Douiri, Nicholas Hart
54 [GO] 2021―Apr―09 Improved asthma control during the COVID-19 pandemic: are there lessons to be learnt? Imogen P Skene, Paul E Pfeffer
55 [GO] 2021―Mar―30 Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales Gwyneth A Davies, Mohammad A Alsallakh, Shanya Sivakumaran, Eleftheria Vasileiou, Ronan A Lyons, Chris Robertson, Aziz Sheikh
56 [GO] 2021―Mar―30 Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data Syed A Shah, Jennifer K Quint, Bright I Nwaru, Aziz Sheikh
57 [GO] 2021―Mar―30 Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study Kyungmin Huh, Young-Eun Kim, Wonjun Ji, Dong Wook Kim, Eun-Joo Lee, Jong-Hun Kim, et al. (+2)
58 [GO] 2021―Mar―23 Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study Belén Pérez-Mies, María Gómez-Rojo, Irene Carretero-Barrio, Tommaso Bardi, Amparo Benito, Mónica García-Cosío, et al. (+5)
59 [GO] 2021―Mar―10 Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score Felix Chua, Rama Vancheeswaran, Adrian Draper, Tejal Vaghela, Matthew Knight, Rahul Mogal, et al. (+18)
60 [GO] 2021―Mar―02 Citizen science in the time of COVID-19 Linda J Birkin, Eleftheria Vasileiou, Helen Ruth Stagg
61 [GO] 2021―Feb―25 Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score Juan Berenguer, Alberto M Borobia, Pablo Ryan, Jesús Rodríguez-Baño, Jose M Bellón, Inmaculada Jarrín, et al. (+5)
62 [GO] 2021―Feb―23 Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis Boun Kim Tan, Sabine Mainbourg, Arnaud Friggeri, Laurent Bertoletti, Marion Douplat, Yesim Dargaud, et al. (+4)
63 [GO] 2021―Feb―17 Effect of public health interventions on COVID-19 cases: an observational study Weihong Qiu, Heng He, Peng Zhang, Wenwen Yang, Tingming Shi, Xing Wang, et al. (+6)
64 [GO] 2021―Feb―15 COVID-19 and what comes after? Nicholas S Hopkinson, Gisli Jenkins, Nicholas Hart
65 [GO] 2021―Feb―12 Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19 Fasihul A Khan, Iain Stewart, Laura Fabbri, Samuel Moss, Karen Robinson, Alan Robert Smyth, Gisli Jenkins
66 [GO] 2021―Feb―05 Identifying patients at risk of post-discharge complications related to COVID-19 infection Jocelin Hall, Katherine Myall, Jodie L Lam, Thomas Mason, Bhashkar Mukherjee, Alex West, Amy Dewar
67 [GO] 2021―Jan―27 Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis Hyun Woo Lee, Chang-Hwan Yoon, Eun Jin Jang, Chang-Hoon Lee
68 [GO] 2021―Jan―06 COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms Joan Loo, Daniella A Spittle, Michael Newnham
69 [GO] 2021―Jan―06 Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people Nicholas S Hopkinson, Niccolo Rossi, Julia El-Sayed_Moustafa, Anthony A Laverty, Jennifer K Quint, Maxim Freidin, et al. (+10)
70 [GO] 2020―Dec―30 Geo-social gradients in predicted COVID-19 prevalence in Great Britain: results from 1 960 242 users of the COVID-19 Symptoms Study app Ruth C E Bowyer, Thomas Varsavsky, Ellen J Thompson, Carole H Sudre, Benjamin A K Murray, Maxim B Freidin, et al. (+11)
71 [GO] 2020―Dec―23 COVID-19 and ‘basal’ exacerbation frequency in COPD Daryl O Cheng, John R Hurst
72 [GO] 2020―Dec―23 Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review Carina S B Tyrrell, Oliver T Mytton, Sarah V Gentry, Molly Thomas-Meyer, John Lee Y Allen, Antony A Narula, et al. (+6)
73 [GO] 2020―Dec―17 Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives Marta Monguió-Tortajada, Antoni Bayes-Genis, Antoni Rosell, Santiago Roura
74 [GO] 2020―Dec―08 SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis Christian Fynbo Christiansen, Anton Pottegård, Uffe Heide-Jørgensen, Jacob Bodilsen, Ole Schmeltz Søgaard, Michael Maeng, et al. (+13)
75 [GO] 2020―Dec―03 Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort David T Arnold, Fergus W Hamilton, Alice Milne, Anna J Morley, Jason Viner, Marie Attwood, et al. (+12)
76 [GO] 2020―Dec―03 Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study Knut Stavem, Waleed Ghanima, Magnus Kringstad Olsen, Hanne Margrethe Gilboe, Gunnar Einvik
77 [GO] 2020―Dec―03 COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations Jing Yuan Tan, Edwin Philip Conceicao, Liang En Wee, Xiang Ying Jean Sim, Indumathi Venkatachalam
78 [GO] 2020―Dec―03 A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations Aditi S Shah, Alyson W Wong, Cameron J Hague, Darra T Murphy, James C Johnston, Christopher J Ryerson, Christopher Carlsten
79 [GO] 2020―Nov―23 Functional respiratory imaging repurposed for COVID-19 Josien van Es, Lilian J Meijboom
80 [GO] 2020―Nov―11 ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 Swapna Mandal, Joseph Barnett, Simon E Brill, Jeremy S Brown, Emma K Denneny, Samanjit S Hare, et al. (+10)
81 [GO] 2020―Nov―11 Severe organising pneumonia following COVID-19 István Vadász, Faeq Husain-Syed, Peter Dorfmüller, Fritz C Roller, Khodr Tello, Matthias Hecker, et al. (+6)
82 [GO] 2020―Nov―04 COPD assessment test for the evaluation of COVID-19 symptoms Enya Daynes, Charlotte Gerlis, Samuel Briggs-Price, Paul Jones, Sally J Singh
83 [GO] 2020―Oct―23 Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19) Daniel J Ryan, Sinead Toomey, Stephen F Madden, Michelle Casey, Oscar S Breathnach, Patrick G Morris, et al. (+11)
84 [GO] 2020―Oct―19 Modification of a domiciliary ventilator to increase FiO2: an off-label modification which may be of value in COVID-19 Yoseph Mebrate, Steven Phillips, Debbie Field, Ivy Mumuni, Paul Josse, David Alexander, et al. (+3)
85 [GO] 2020―Sep―23 Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection Sang Hyun Ra, Joon Seo Lim, Gwang-un Kim, Min Jae Kim, Jiwon Jung, Sung-Han Kim
86 [GO] 2020―Sep―11 SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study Adrian Shields, Sian E Faustini, Marisol Perez-Toledo, Sian Jossi, Erin Aldera, Joel D Allen, et al. (+28)
87 [GO] 2020―Sep―02 Caring for patients with COPD and COVID-19: a viewpoint to spark discussion Sami O Simons, John R Hurst, Marc Miravitlles, Frits M E Franssen, Daisy J A Janssen, Alberto Papi, et al. (+2)
88 [GO] 2020―Aug―28 Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19 Muhunthan Thillai, Chinmay Patvardhan, Emilia M Swietlik, Tom McLellan, Jan De Backer, Maarten Lanclus, et al. (+2)
89 [GO] 2020―Aug―27 Drive-through testing for SARS-CoV-2 in symptomatic health and social care workers and household members: an observational cohort study Benjamin J Parcell, Kathryn Brechin, Sarah Allstaff, Meg Park, Wendy Third, Susan Bean, et al. (+4)
90 [GO] 2020―Aug―24 Respiratory follow-up of patients with COVID-19 pneumonia Peter M George, Shaney L Barratt, Robin Condliffe, Sujal R Desai, Anand Devaraj, Ian Forrest, et al. (+7)
91 [GO] 2020―Aug―24 Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients Borja Recalde, Laura García-Tobar, Alan Argueta, Laura Álvarez, Carlos Eduardo De Andrea, Mirian Fernández Alonso, et al. (+9)
92 [GO] 2020―Aug―13 Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey Barnaby Flower, Jonathan C Brown, Bryony Simmons, Maya Moshe, Rebecca Frise, Rebecca Penn, et al. (+32)
93 [GO] 2020―Aug―03 Tension pneumomediastinum in patients with COVID-19 Alessio Campisi, Venerino Poletti, Angelo Paolo Ciarrocchi, Maurizio Salvi, Franco Stella
94 [GO] 2020―Jul―23 High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection Andrea Vianello, Giovanna Arcaro, Beatrice Molena, Cristian Turato, Andi Sukthi, Gabriella Guarnieri, et al. (+3)
95 [GO] 2020―Jun―24 Asymptomatic SARS-CoV-2 infection: the tip or the iceberg? Alexander J Keeley, Cariad M Evans, Thushan I de Silva
96 [GO] 2020―Jun―16 Awake prone positioning in COVID-19 David Koeckerling, Joseph Barker, Nadeesha L Mudalige, Oluwatobiloba Oyefeso, Daniel Pan, Manish Pareek, et al. (+2)
97 [GO] 2020―Jun―10 Treating asthma in the COVID-19 pandemic Ran Wang, Andras Bikov, Stephen J Fowler
98 [GO] 2020―May―28 COVID-19: in the footsteps of Ernest Shackleton Alvin J Ing, Christine Cocks, Jeffery Peter Green
99 [GO] 2020―May―27 SARS-CoV-2 pandemic: clinical picture of COVID-19 and implications for research Marc Lipman, Rachel Clare Chambers, Mervyn Singer, Jeremy Stuart Brown
100 [GO] 2020―May―23 Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology Katrina Abernethy, Parthipan Sivakumar, Tanya Patrick, Hastie Robbie, Jimstan Periselneris
101 [GO] 2020―Apr―24 Two for one with split- or co-ventilation at the peak of the Covid-19 tsunami: is there any role for communal care when the resources for personalised medicine are exhausted? Steven Dale Pearson, Jesse B Hall, William F Parker
102 [GO] 2020―Apr―21 Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT Aniket N Tavare, Aaron Braddy, Simon Brill, Hannah Jarvis, Anand Sivaramakrishnan, Joseph Barnett, et al. (+2)
103 [GO] 2020―Apr―09 Case for continuing community NIV and CPAP during the COVID-19 epidemic Jillian G Baker, Milind Sovani
104 [GO] 2020―Apr―09 COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life Joseph Barker, Oluwatobiloba Oyefeso, David Koeckerling, Nadeesha Lakmal Mudalige, Daniel Pan

104 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec